PUBLISHER: The Business Research Company | PRODUCT CODE: 1939232
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939232
Antimicrobial hospital textiles are fabrics treated with chemicals or manufactured with antimicrobial properties to restrict the growth of bacterial germs on the material. These textiles find application in hospital settings for items such as beds, curtains, and linens.
The primary types of antimicrobial hospital textiles include cotton, polyester, polyamide, and other varieties such as polyethylene, polypropylene, acrylic, and cellulose acetate. Cotton, a staple fiber composed of numerous fibers of varying lengths, is used in both disposable and reusable forms, falling under FDA class I, class II, and class III categories. These textiles are employed in various hospital departments, including general wards, surgical rooms, infectious disease wards, ICUs, and others. Their versatile applications encompass medical uniforms and apparel, upholstery, surgical textiles, incontinence care garments, wound treatment, and various other medical uses.
Tariffs are impacting the antimicrobial hospital textiles market by increasing costs of imported specialty fibers, antimicrobial agents, textile coatings, and advanced manufacturing equipment. Hospitals and healthcare institutions in North America and Europe are most affected due to reliance on imported treated fabrics, while Asia-Pacific faces pricing pressure on textile exports. These tariffs are raising procurement costs for healthcare facilities. However, they are also encouraging domestic textile manufacturing, regional sourcing of antimicrobial materials, and innovation in cost-efficient hospital textile solutions.
The antimicrobial hospital textiles market research report is one of a series of new reports from The Business Research Company that provides antimicrobial hospital textiles market statistics, including antimicrobial hospital textiles industry global market size, regional shares, competitors with a antimicrobial hospital textiles market share, detailed antimicrobial hospital textiles market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial hospital textiles industry. This antimicrobial hospital textiles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The antimicrobial hospital textiles market size has grown strongly in recent years. It will grow from $11.13 billion in 2025 to $12.18 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increasing hospital-acquired infection concerns, expansion of healthcare infrastructure, rising usage of medical uniforms and linens, growing awareness of hygiene standards, availability of antimicrobial fabric technologies.
The antimicrobial hospital textiles market size is expected to see strong growth in the next few years. It will grow to $17.4 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for sustainable medical textiles, rising focus on reusable hospital products, expansion of infection prevention protocols, growing adoption of advanced antimicrobial materials, increasing regulatory emphasis on hospital hygiene. Major trends in the forecast period include increasing adoption of antimicrobial textile treatments, rising demand for infection-control hospital fabrics, growing use of reusable antimicrobial textiles, expansion of icu and surgical textile applications, enhanced focus on patient safety and hygiene.
The growing awareness of hospital-acquired infections is anticipated to support the expansion of the antimicrobial hospital textiles market in the coming years. Hospital-acquired infections refer to infections contracted during the course of medical treatment at a healthcare facility, often transmitted by healthcare professionals such as doctors or nurses. Antimicrobial hospital textiles contribute to lowering the incidence of these infections by limiting the growth and spread of bacteria that affect the digestive system, urinary tract, skin, lungs, and bloodstream. For example, in June 2025, data published by the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that during 2023-24, hospital-acquired complications were reported in approximately 150,000 hospitalizations out of a total of 12.6 million hospitalizations. Consequently, increased awareness of hospital-acquired infections is supporting the growth of the antimicrobial hospital textiles market.
Leading companies in the antimicrobial hospital textiles market are increasingly concentrating on the development of innovative products, such as copper-infused, eco-healthtech medical scrubs, to address the rising need for infection control and prevention of hospital-acquired infections in healthcare environments. These scrubs incorporate copper into natural materials such as cotton, bamboo, and linen, providing long-lasting antimicrobial performance. Unlike conventional scrubs that rely mainly on repeated laundering or surface disinfectants, these fabrics inherently limit microbial growth. For instance, in June 2023, Swiss Precision Active, a Switzerland-based eco-healthtech apparel company, introduced its CopperActive antimicrobial scrubs at the FIME Miami Fair. The CopperActive range uses a patented combination of copper and natural organic fibers, is laboratory tested and verified by SGS and other testing facilities, and is designed to kill or inhibit harmful bacteria over time. The scrubs are lightweight, moisture-wicking, odour-resistant, and retain their antimicrobial effectiveness even after repeated washing, making them well suited for high-risk hospital settings where reducing pathogen transmission is critical.
In October 2024, 1888 Mills Inc., a United States-based manufacturer of textiles and fabric solutions, entered into a partnership with Fuze Technologies Inc. Through this collaboration, 1888 Mills plans to incorporate Fuze Technologies' antimicrobial technologies into its textile offerings to improve hygiene, safety, and durability across commercial and hospitality applications. Fuze Technologies Inc., a United States-based technology company, specializes in the development of antimicrobial surface treatments and technologies that inhibit the growth of bacteria and other pathogens on fabrics and surfaces.
Major companies operating in the antimicrobial hospital textiles market are Sinterama S.p.A., Trevira GmbH, PurThread Technologies Inc., LifeThreads LLC, Thai Acrylic Fiber Co. Ltd., Herculite Products Inc., Toyobo Co. Ltd., Baltex Group Limited, Microban International Ltd., Sciessent LLC, BASF SE, Lonza Group AG, BioCote Limited, Resil Chemicals Pvt. Ltd., Archroma Management LLC, HeiQ Materials AG, Milliken & Company, Vestagen Technical Textiles Inc., Copper Clothing Ltd., Applied Silver Inc., 3M Company, Ahlstrom-Munksjo Oyj, American Dawn Inc., Medline Industries Inc., Angelica Corporation, Hospital Specialty Company Inc., BSN Medical Inc., Cramer Products Inc.
Asia-Pacific was the largest region in the antimicrobial hospital textiles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the antimicrobial hospital textiles market report during the forecast period. The regions covered in the antimicrobial hospital textiles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the antimicrobial hospital textiles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The antimicrobial hospital textiles market consists of sales of medical curtains, bed sheets and pillow coverings, and mattresses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antimicrobial Hospital Textiles Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses antimicrobial hospital textiles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for antimicrobial hospital textiles ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial hospital textiles market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.